Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial
Clinical Cancer Research, 10/19/09
Evens AM et al. – This represents the first report of a novel agent to be combined safely concurrently with radioimmunotherapy. Furthermore, tumor responses with [90Y]ibritumomab tiuxetan/motexafin gadolinium were prompt with a high rate of CRs, especially in rituximab–refractory follicular lymphoma.
Related Articles
Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09
Relevance Score: 68%
Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma
Cancer Management and Research, 10/23/09
Relevance Score: 67%
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
Annals of Oncology, 10/29/09
Relevance Score: 66%
Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
British Journal of Clinical Pharmacology, 10/22/09
Relevance Score: 64%
Non-Hodgkin's Lymphoma of Supraclavicular Lymph Nodes Can Mimic Metastasis of Breast Cancer During Chemotherapy on FDG PET/CT
Clinical Nuclear Medicine, 10/06/09
Relevance Score: 64%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib
Experimental Hematology, 12/15/09
Constant BCR-ABL transcript level >=0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis
Experimental Hematology, 12/15/09
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkins lymphoma
European Journal of Haematology, 12/14/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: Implication in oxidative stress
Cancer Chemotherapy and Pharmacology, 12/15/09
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
Cancer Chemotherapy and Pharmacology, 12/14/09
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
Cancer, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


